Dipna Pharmachem [DPL] vs Trident Lifeline [TLL] Detailed Stock Comparison

Dipna Pharmachem

BSE

Trident Lifeline

BSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dipna Pharmachem wins in 6 metrics, Trident Lifeline wins in 12 metrics, with 0 ties. Trident Lifeline appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Dipna Pharmachem	Trident Lifeline	Better
P/E Ratio (TTM)	55.73	23.82	Trident Lifeline
Price-to-Book Ratio	1.39	4.61	Dipna Pharmachem
Debt-to-Equity Ratio	44.74	77.58	Dipna Pharmachem
PEG Ratio	N/A	0.28	N/A
EV/EBITDA	20.51	18.49	Trident Lifeline
Profit Margin (TTM)	0.78%	13.27%	Trident Lifeline
Operating Margin (TTM)	5.69%	15.70%	Trident Lifeline
EBITDA Margin (TTM)	5.69%	15.70%	Trident Lifeline
Return on Equity	2.56%	16.87%	Trident Lifeline
Return on Assets (TTM)	1.61%	7.53%	Trident Lifeline
Free Cash Flow (TTM)	$-92.15M	$-213.41M	Dipna Pharmachem
Dividend Yield	23.16%	N/A	N/A
1-Year Return	-94.60%	-11.55%	Trident Lifeline
Price-to-Sales Ratio (TTM)	0.45	3.08	Dipna Pharmachem
Enterprise Value	$704.19M	$3.28B	Trident Lifeline
EV/Revenue Ratio	0.56	3.37	Dipna Pharmachem
Gross Profit Margin (TTM)	44.45%	53.63%	Trident Lifeline
Revenue per Share (TTM)	$53	$81	Trident Lifeline
Earnings per Share (Diluted)	$0.41	$10.88	Trident Lifeline
Beta (Stock Volatility)	-0.21	-0.15	Dipna Pharmachem

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Dipna Pharmachem vs Trident Lifeline Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Dipna Pharmachem	-0.17%	-1.90%	5.17%	5.78%	74.72%	62.99%
Trident Lifeline	-4.97%	-1.69%	-9.70%	-16.27%	-0.17%	-8.75%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Dipna Pharmachem	-94.60%	-88.33%	-54.14%	-78.61%	-79.07%	-79.07%
Trident Lifeline	-11.55%	103.89%	103.89%	103.89%	103.89%	103.89%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Dipna Pharmachem (DPL): View Full Stock Overview

Trident Lifeline (TLL): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Dipna Pharmachem vs Trident Lifeline

Metric	DPL	TLL
Market Information
Market Cap i	₹564.97M	₹3.00B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	44,400	7,020
90 Day Avg. Volume i	82,700	4,720
Last Close	₹23.78	₹259.15
52 Week Range	₹11.45 - ₹542.55	₹222.00 - ₹339.00
% from 52W High	-95.62%	-23.55%
All-Time High	₹558.00 (Jan 29, 2024)	₹339.00 (Sep 02, 2024)
% from All-Time High	-95.74%	-23.55%
Growth Metrics
Quarterly Revenue Growth	-0.62%	0.80%
Quarterly Earnings Growth	0.29%	0.74%
Financial Health
Profit Margin (TTM) i	0.01%	0.13%
Operating Margin (TTM) i	0.06%	0.16%
Return on Equity (TTM) i	0.03%	0.17%
Debt to Equity (MRQ) i	44.74	77.58
Cash & Liquidity
Book Value per Share (MRQ)	₹16.40	₹56.20
Cash per Share (MRQ)	₹0.18	₹2.35
Operating Cash Flow (TTM) i	₹-91,946,000	₹-171,590,000
Levered Free Cash Flow (TTM) i	₹-123,409,000	₹117.48M
Dividends
Last 12-Month Dividend Yield i	23.16%	N/A
Last 12-Month Dividend i	₹5.00	N/A

Valuation & Enterprise Metrics Analysis: Dipna Pharmachem vs Trident Lifeline

Metric	DPL	TLL
Price Ratios
P/E Ratio (TTM) i	55.73	23.82
Forward P/E i	N/A	N/A
PEG Ratio i	N/A	0.28
Price to Sales (TTM) i	0.45	3.08
Price to Book (MRQ) i	1.39	4.61
Market Capitalization
Market Capitalization i	₹564.97M	₹3.00B
Enterprise Value i	₹704.19M	₹3.28B
Enterprise Value Metrics
Enterprise to Revenue i	0.56	3.37
Enterprise to EBITDA i	20.51	18.49
Risk & Other Metrics
Beta i	-0.21	-0.15
Book Value per Share (MRQ) i	₹16.40	₹56.20

Financial Statements Comparison: Dipna Pharmachem vs Trident Lifeline

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	DPL	TLL
Revenue/Sales i	₹1.48B	₹460.46M
Cost of Goods Sold i	₹823.75M	₹263.01M
Gross Profit i	₹659.26M	₹197.44M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹362.82M	₹-2.89M
EBITDA i	₹1.44B	₹100.19M
Pre-Tax Income i	₹1.13B	₹38.56M
Income Tax i	₹455.55M	₹1.00M
Net Income (Profit) i	₹676.72M	₹37.56M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	DPL	TLL
Cash & Equivalents i	₹4.26M	₹24.61M
Total Current Assets i	₹1.32B	₹903.71M
Total Current Liabilities i	₹849.96M	₹535.55M
Long-Term Debt i	₹88.90M	₹322.73M
Total Shareholders Equity i	₹384.93M	₹696.50M
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹459,000	₹349.63M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	DPL	TLL
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	DPL	TLL
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	44,400	7,020
Average Daily Volume (90 Day) i	82,700	4,720
Shares Outstanding i	24.05M	11.50M
Float Shares i	7.91M	3.48M
% Held by Insiders i	0.45%	0.77%
% Held by Institutions i	0.00%	0.00%

Dividend Analysis & Yield Comparison: Dipna Pharmachem vs Trident Lifeline

Metric	DPL	TLL
Last 12-Month Dividend i	₹5.00	N/A
Last 12-Month Dividend Yield i	23.16%	N/A
3-Year Avg Annual Dividend i	₹6.00	N/A
3-Year Avg Dividend Yield i	1.72%	N/A
3-Year Total Dividends i	₹18.00	N/A
Ex-Dividend Date	Aug 13, 2024	N/A

Dipna Pharmachem [DPL] vs Trident Lifeline [TLL] Detailed Stock Comparison